Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target class encompasses the diverse structural and functional molecules located on the exterior of microbial cells and within the surrounding extracellular matrix of biofilms. Cell surface macromolecules, such as peptidoglycan in bacteria and chitin in fungi, provide structural rigidity and are essential for survival, making them primary targets for traditional antibiotics (StatPearls, 2023). Biofilm matrix components, collectively known as extracellular polymeric substances (EPS), include polysaccharides, proteins, and extracellular DNA that shield microbial communities from host immune responses and environmental stressors (Nature Reviews Microbiology, 2010). These components play a critical role in the pathogenesis of chronic and healthcare-associated infections by facilitating adhesion to surfaces and promoting antimicrobial tolerance (NIH, 2021). Therapeutic strategies targeting these structures range from inhibiting the biosynthesis of cell wall polymers to the enzymatic degradation of the established biofilm matrix to enhance drug penetration (PubMed, 2018). Understanding the composition and regulation of these macromolecules is vital for developing next-generation anti-infectives that can overcome the challenges of biofilm-mediated resistance.
Drugs targeting these components typically inhibit the synthesis of essential cell wall polymers (e.g., peptidoglycan, beta-glucan), disrupt the structural integrity of the microbial membrane (e.g., via lipopolysaccharide interaction), or enzymatically degrade the extracellular polymeric substances that constitute the biofilm matrix to facilitate microbial clearance and improve antibiotic penetration (Nature Reviews Microbiology, 2010; StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell surface macromolecules and biofilm matrix components.